Read More Health and Medicine Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status [ad_1] New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to… bychemistadminMarch 20, 2024